Abstract:Background and purpose: The prognosis of herpes simplex encephalitis (HSE) remains poor despite available antiviral treatment. Matrix metalloproteinase-9 (MMP-9) is currently considered to play a major role in promoting cerebrovascular complications which contribute to the high mortality and morbidity of HSE. We hypothesize that temporally knockdown MMP-9 expression in early phase of HSE might be an effective treatment strategy. Methods: The animal models of herpes simplex encephalitis were established by intracerebrally inoculated herpes simplex virus type 1 (HSV-1) in mice. Mice were inoculated intracerebrally with MMP-9 targeting siRNA (MMP-9 siRNA). MMP-9 expression was assessed by RT-PCR and western blot analysis at 3 and 7 days after HSV-1 infected. The blood-brain barrier (BBB) permeability was quantitated by Evans blue dye extravasations and brain water content. Immunohistochemistry method was adopted to analyse the expression of AQP4 protein. Quantitative real-time PCR analysis was used to detect cytokines expression. Neurological score was quantified using an established neurological scale at 7 days after HSE. Results: Using synthetic small interfering RNA, we found a single intracerebral injection of siRNA targeting murine MMP-9 mRNA (MMP-9 siRNA) silenced MMP-9 expression and reduced it to normal level at day 7 post-infection. The improvement in neurological function and increased cumulative survival reflected the functional consequence of this therapy. MMP-9 knockdown mice also displayed less uptake of Evans blue and reduced brain water content compared with control siRNA-treated group. Also the HSV-1-induced up-regulation of proinflammatory cytokines was significantly diminished in MMP-9 siRNA-treated mice. In addition, aquaporin-4 expression in perivascular decreased in MMP-9 siRNA-treated mice and might contribute to the protection of blood-brain barrier. Discussion: This compelling evidence suggests that MMP-9 is a key pathogenic factor within HSE, and local injection of synthetic siRNA in the brain could knock down MMP-9 expression in acute phase of HSE, reduce brain edema and improves mice neurological function and increase cumulative survival.

Therapeutic Application of Gene Silencing Mmp-9 in A Middle Cerebral Artery Occlusion-Induced Focal Ischemia Rat Model

Lentivirus-Mediated Transfer Of Mmp-9 Shrna Provides Neuroprotection Following Focal Ischemic Brain Injury In Rats

Ischemic Postconditioning Diminishes Matrix Metalloproteinase 9 Expression and Attenuates Loss of the Extracellular Matrix Proteins in Rats Following Middle Cerebral Artery Occlusion and Reperfusion

Early Inhibition of HIF-1α with Small Interfering RNA Reduces Ischemic–reperfused Brain Injury in Rats

MMP-9 Gene Silencing by a Quantum Dot–sirna Nanoplex Delivery to Maintain the Integrity of the Blood Brain Barrier

Mmp-9, a Potential Target for Cerebral Ischemic Treatment.

Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia

Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice.

Matrix Metalloproteinase-9 Inhibition Attenuates Vascular Endothelial Growth Factor-Induced Intracerebral Hemorrhage

Inhibition of miR-423-5p exerts neuroprotective effects in an experimental rat model of cerebral ischemia/reperfusion injury

Abstract 2058: Expression of Brain MMP9 in a Rat Model of Cardiopulmonary Resuscitation Treated with SB-3CT

Molecular Mechanisms for NG-nitro-L-arginine Methyl Ester Action Against Cerebral Ischemia–reperfusion Injury-Induced Blood–brain Barrier Dysfunction

Efficiency and Safety of Β-Cd-(d3)7 As Sirna Carrier for Decreasing Matrix Metalloproteinase-9 Expression and Improving Wound Healing in Diabetic Rats.

Inhibition of MMP-9 Activity through the Delivery of TIMP-1 Encoding Synthetic mRNA into Arteries

Inhibition of NHE-1 Mrna Expression in Penumbra Area by Human Interleukin-10 Transfection Following Cerebral Ischemia-Reperfusion Injury in Rats

Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery Via Glial Scar Degradation and Angiogenesis in Delayed Stroke

Reduced Ischemic Injury After Stroke in Mice by Angiogenic Gene Delivery Via Ultrasound-Targeted Microbubble Destruction

Favorable effects of MMP-9 knockdown in murine herpes simplex encephalitis using small interfering RNA.

Effect of resveratrol on marix metalloproteinase 9 (MMP-9) induced by cerebral ischemia-reperfusion in mice

Expression of MMP-9 after Cerebral Ischemic Reperfusion and the Effects of Artificial Synthetic E-selectin in Rats

Identification of the biological function of miR-9 in spinal cord ischemia-reperfusion injury in rats